Among those undergoing neuroendoscopic lavage and receiving a ventriculoperitoneal shunt, 12-month shunt survival was 73.1%, a significant improvement over historical outcomes. Neuroendoscopic lavage ...

We present the second case, in medical literature, of intracranial hypertension caused by ventriculoperitoneal shunt (VPS) migration into the breast, in a 31-year-old woman who had breast silicone ...

Background Venous sinus stenting has emerged as an effective treatment for cerebral venous outflow disorders (CVD), historically targeting transverse and superior sagittal sinus stenoses. However, the ...

Hydrocephalus is an excess of cerebrospinal fluid (CSF) in the brain’s ventricles. Surgery is the first-line and most effective treatment. The two primary surgeries are the Ventriculoperitoneal (VP) ...

When music legend Billy Joel revealed that he had been diagnosed with normal pressure hydrocephalus (NPH) in 2025, he did more than share a personal health update—he shed light on a little-known but ...

Abstract: Ventriculoperitoneal (VP) shunt placement is a vital technique for managing patients with hydrocephalus. However, the procedure encounters challenges due to the insufficient accuracy of ...

This work was supported by HCA Healthcare and/or an HCA Healthcare affiliated entity. The views expressed in this publication represent those of the author(s) and do not necessarily represent the ...

BOSTON, April 23, 2025 /PRNewswire/ -- CereVasc, Inc., a clinical-stage, medical device company developing novel treatments for neurological diseases, today announced it has received its second ...

Prior to the high-volume LP, Mr. M was carefully evaluated for gait, cognition, and memory. Then between 30 and 50 ml of CSF was removed and he was reevaluated several hours later using the same ...

ABSTRACT: Background: Lumboperitoneal (LP) shunts have been used to manage benign intracranial hypertension (BIH) for an extended period. While they may swiftly and effectively alleviate symptoms, ...